Lv21
166 积分 2023-12-21 加入
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
10天前
已完结
In vivo detection of immune responses via cytokine activity labeling
22天前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
1个月前
已完结
In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles
3个月前
已完结
Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys
3个月前
已完结
Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies
4个月前
已完结
ABS0200 KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO
4个月前
已关闭
Rapid in silico directed evolution by a protein language model with EVOLVEpro
4个月前
已完结
Peptide codes for organ-selective mRNA delivery
5个月前
已完结
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
5个月前
已完结
皖公网安备34019202002308
